October 24, 2012
In this video, Fool.com analysts David Williamson and Max Macaluso discuss United Therapeutics and Discovery Laboratories' 15% intraday plunges. One received an FDA rejection and the other had a familiar problem rear its ugly head. Watch and find out what this means for these stocks, their competitors, and investors.
While you can certainly make huge gains in biotech and pharmaceuticals, the best investing approach is to choose great companies and stick with them for the long term. In our free report "3 Stocks That Will Help You Retire Rich," we name stocks that could help you build long-term wealth and retire well, along with some winning wealth-building strategies that every investor should be aware of. Click here now to keep reading.